"Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Descriptor ID |
D009374
|
MeSH Number(s) |
C04.619 E05.598.500.496
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Experimental".
- Neoplasms, Experimental
- Carcinoma 256, Walker
- Carcinoma, Brown-Pearce
- Carcinoma, Ehrlich Tumor
- Carcinoma, Krebs 2
- Carcinoma, Lewis Lung
- Leukemia, Experimental
- Liver Neoplasms, Experimental
- Mammary Neoplasms, Experimental
- Melanoma, Experimental
- Sarcoma, Experimental
This graph shows the total number of publications written about "Neoplasms, Experimental" by people in this website by year, and whether "Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2011 | 1 | 2 | 3 |
2012 | 0 | 1 | 1 |
2013 | 2 | 3 | 5 |
2014 | 3 | 0 | 3 |
2015 | 1 | 2 | 3 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 0 | 2 | 2 |
2019 | 2 | 0 | 2 |
2020 | 0 | 2 | 2 |
2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Experimental" by people in Profiles.
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
-
Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure-activity relationship, in vitro and in vivo evaluation as antitumor agents. Bioorg Med Chem Lett. 2021 06 01; 41:127923.
-
The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity. Bioorg Med Chem. 2021 01 01; 29:115887.
-
Studies on interaction potency model based on drug synergy and therapeutic potential of triple stimuli-responsive delivery of doxorubicin and 5-fluoro-2-deoxyuridine against lymphoma using disulfide-bridged cysteine over mesoporous silica nanoparticles. J Mater Chem B. 2020 02 21; 8(7):1411-1421.
-
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model. Cancer Prev Res (Phila). 2020 02; 13(2):185-194.
-
Tackling Acute Lymphoblastic Leukemia-One Fish at a Time. Int J Mol Sci. 2019 Oct 25; 20(21).
-
Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential. Bioorg Med Chem Lett. 2018 10 01; 28(18):3085-3093.
-
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. ACS Nano. 2018 08 28; 12(8):8423-8435.
-
Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells. Biomaterials. 2017 03; 121:55-63.
-
Tuning photothermal properties of gold nanodendrites for in vivo cancer therapy within a wide near infrared range by simply controlling their degree of branching. Biomaterials. 2016 10; 104:138-44.